NetQuantum :: Business :: Biotechnology_and_Pharmaceuticals :: Pharmaceuticals ::

• Why Clean Tech Is Taking Biotech's Shine
Nigel Beeley is a biopharma veteran. He spent 25 years in research at such biotechnology companies as Amylin Pharmaceuticals (AMLN), Arena Pharmaceuticals (ARNA), and Senomyx (SNMX). He had a hand in creating cancer and metabolic disease drugs ...
• Maybe You Can Bail Out the Banks
GSK), Teva Pharmaceuticals (Nasdaq: TEVA), and America Movil (NYSE: AMX) as top holdings. Looking into individual stocks, some of which can deliver rapid growth for many years. Deere (NYSE: DE), for example, has grown by an annual average of 13% over the ...
• The stunning collapse of Iceland
The banks, in large part, were simply following the international ambitions of a new generation of Icelandic entrepreneurs who forged global empires in industries from retailing to food production to pharmaceuticals. By the end of 2006, the total ...
• 5 Stocks Approaching Greatness
... through CAPS' proprietary ratings system, we've found a handful of four-star firms approaching greatness: Amkor Technology (Nasdaq: AMKR) Cytori Therapeutics (Nasdaq: CYTX) DRDGOLD (Nasdaq: DROOY) Flamel Technologies (Nasdaq: FLML) Watson Pharmaceuticals (NYSE ...
• Teva Heads to Japan
Teva Pharmaceuticals ' (Nasdaq: TEVA) plan to conquer the world seems to be coming along nicely. It'll make inroads into Europe with the acquisition of Barr Pharmaceuticals (NYSE: BRL), and now it's moving into Japan. The generic-drug maker is ...